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ABSTRACT
Background: Epicutaneous sensitization to allergens is important in the pathogenesis of not only skin inflam-
mation such as atopic dermatitis but also “atopic march” in allergic diseases such as asthma and food allergies.
We here examined antibody production and skin barrier dysfunction in mice epicutaneously administered pa-
pain, a plant-derived occupational allergen belonging to the same family of cysteine proteases as mite major
group 1 allergens.
Methods: Papain and Staphylococcus aureus V8 protease were patched on the backs of hairless mice. Tran-
sepidermal water loss was measured to evaluate the skin barrier dysfunction caused by the proteases. Papain
or that treated with an irreversible inhibitor specific to cysteine proteases, E64, was painted onto the ear lobes
of mice of an inbred strain C57BL6. Serum total IgE levels and papain-specific IgE and IgG antibodies were
measured by ELISA.
Results: Papain and V8 protease patched on the backs of hairless mice caused skin barrier dysfunction
and increased serum total IgE levels, and papain induced the production of papain-specific IgG1, IgG2a,
and IgG2b. Papain painted onto the ear lobes of C57BL6 mice induced papain-specific IgE, IgG1, IgG2c, and
IgG2b, whereas papain treated with E64 did not. IgG1 was the most significantly induced papain-specific IgG
subclass among those measured.
Conclusions: We demonstrated that the epicutaneous administration of protease not only disrupted skin bar-
rier function, but also induced IgE and IgG responses in a manner dependent on its protease activity. These re-
sults suggest that protease activity contained in environmental sources contributes to sensitization through an
epicutaneous route.
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INTRODUCTION
The protease activity of allergens has been implicated
as an important property that endows an allergen
with its allergenicity.1-7 The protease activity of the
house dust mite major group 1 allergens Der f 1 and
Der p 1, two of the most important allergens common
worldwide, has been shown to cause barrier dysfunc-
tion in the mucosal epithelium and skin, induce the
production of pro-inflammatory cytokines in epithelial
cells and keratinocytes, cleave various molecules,
modulate the functions of various cell types, and in-
duce Th2 responses.1,3,5-16 Previous studies reported
that papain, a papaya fruit-derived occupational
protease allergen, stimulated epithelial cells17 and
mouse basophils in vitro16,18,19 and induces Th2 re-
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sponses16,18-21 and the IL-33-dependent innate22 and
adaptive16 responses of lung eosinophilia in mice.
The repeated intranasal administration of papain and
recombinant Der f 1 without using adjuvants such as
Alum induced allergic airway inflammation and IgE
IgG1 production in a manner dependent of the pro-
tease activity of the protease allergens in mice.16
Skin barrier dysfunction has been reported as a
major manifestation of atopic dermatitis, and its in-
volvement in the pathogenesis has been re-
ported.1,2,23,24 Furthermore, epicutaneous sensitiza-
tion through barrier-disrupted skin has been shown
to cause the “atopic march” in allergic diseases such
as asthma and food allergies.1,23,25,26 We previously
demonstrated that the recombinant mite major pro-
tease allergen Der f 19 and Staphylococcus aureus V8
protease27 applied to the skin of mice caused skin
barrier dysfunction. These results suggest that the
proteases contained in allergen sources and those
produced by skin-resident microbes contribute to a
reduction in skin barrier function, which initiates and
promotes allergen-sensitization through the skin.1
However, whether exposure of the skin to proteases
causes IgE production remains unknown. In the pre-
sent study, we examined antibody production after
the epicutaneous administration of proteases without
using adjuvants.
METHODS
MICE
Six-to twelve-week-old female hairless mice (Skh:
HR1 strain; Hoshino Laboratory Animals, Inc., Iba-
raki, Japan) and C57BL6N mice (Japan SLC, Inc.,
Hamamatsu, Japan) were maintained in a specific
pathogen-free animal facility at Juntendo University
and used in accordance with the guidelines of the in-
stitutional committee on animal experiments.
EPICUTANEOUS ADMINISTRATION OF PAPAIN
TO THE BACKS OF HAIRLESS MICE
A rectangular piece of filter paper 1 cm × 2 cm (3MM
Chr, Whatmann, Middlesex, UK) was placed on the
backs of hairless mice without tape stripping, and
PBS (100 μl2 cm2site), papain (Calbiochem, San
Diego, CA, USA) (50 μg100 μl-PBS2 cm2site), or
S. aureus V8 protease (Pierce, Rockford, IL, USA) (5
μg100 μl-PBS2 cm2site) was perfused to the pa-
per. Paper containing PBS, papain, or V8 protease
was wrapped and immobilized with a polyurethane
film (Cathereep; Nichiban, Tokyo, Japan). The direct
application of PBS without the patch and occlusion
were performed in other mice as a control group. Ap-
plications were repeated on days 0-6 and days 9-15.
MEASUREMENT OF TRANSEPIDERMAL WATER
LOSS IN HAIRLESS MICE
Transepidermal water loss (TEWL) was measured
with a Mobile Tewameter (Courage + Khazaka Elec-
tronic GmbH, Köln, Germany) on days 0 and 9 before
the application and on day 16.
ELISA FOR SERUM ANTIBODY PRODUCTION IN
HAIRLESS MICE
Sera were collected on days 8 and 16 to measure anti-
body production by ELISA. Serum total IgE was
measured by a sandwich ELISA as described previ-
ously.28,29 Papain-specific antibodies were detected as
described previously16,30,31 with modifications as fol-
lows. Plates were coated with 30 μgml of papain,
blocked with BlockAce (Snow Bland, Sapporo, Ja-
pan), and developed with HRP-conjugated antibodies
specific to the murine IgG1 (rat monoclonal antibody,
clone X56: BD Biosciences, San Jose, CA, USA),
IgG2a (rat monoclonal antibody, clone R19-15; BD Bi-
osciences), and IgG2b (Rabbit polyclonal antibody;
Zymed, South San Francisco, CA, USA).30,31 Sera and
detection antibodies were diluted with Solutions 1
and 2 of CanGetSignal (TOYOBO, Osaka, Japan), re-
spectively. Serum dilutions were 110000, 1200, and
1200 for detecting papain-specific IgG1, IgG2a, and
IgG2b, respectively. Incubation with sera or detection
antibodies to detect papain-specific IgG subclasses
was for 1.5 h at room temperature. Dilutions of HRP-
conjugated detection antibodies were 14000. The op-
tical density (OD) at 450 nm, from which that at 570
nm was subtracted, was used as the signal for papain-
specific IgGs.
TREATMENT OF PAPAIN WITH E64
Papain was treated with the irreversible inhibitor spe-
cific to cysteine proteases, E64 (Peptide Institute,
Osaka, Japan), as described previously14 with minor
modifications.16 After the treatment, free E64 was re-
moved by dialysis. Papain, which was incubated simi-
larly to E64-treated papain (but without the addition
of E64) and dialyzed, was prepared and used for
epicutaneous administration to C57BL6 mice. Purity
and the absence of both degradation and aggregation
were confirmed by electrophoresis, and protease ac-
tivity was analyzed using synthetic fluorogenic sub-
strates.14,32
EPICUTANEOUS ADMINISTRATION OF PAPAIN
TO THE EAR LOBES OF C57BL6 MICE
This method was originally described for sensitiza-
tion to mite extract by Gao et al.33 and we modified it
for sensitization to papain as follows. Tape stripping
was not performed in the present study. 12.5 μl of 10
mgml of papain or E64-treated papain was applied
onto both sides of both ear lobes (250 μg25 μlani-
mal) on days 0, 3, 7, 10, 21, 24, and 28 for a total of 7
times.
ELISA FOR SERUM ANTIBODY PRODUCTION IN
C57BL6 MICE
Sera were collected on days 17 and 35 to measure an-
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Fig.　1　Papain and S. aureus V8 protease patched on the backs of hair-
less mice caused skin barrier dysfunction and increased serum total IgE 
levels. A patch containing PBS, papain, or V8 protease with occlusion was 
applied to the backs of hairless mice and immobilized with a polyurethane 
fi lm every day on days 0-6 and days 10-15. In the control group, PBS was 
directly applied without the patch and occlusion (Control). TEWL was mea-
sured on days 0 and 9 before the application and day 16 (A). Sera were 
collected from mice in on days 8 and 16. IgE concentrations were mea-
sured by ELISA (B). *p < 0.05 signifi cantly different from Control and #p < 
0.05 signifi cantly different from PBS by a one-way ANOVA and Tukey post 
hoc test, and $p < 0.05 signifi cantly different from PBS by a t-test (two-
tailed). Data shown are the means ± SDs for four or three mice/group and 
are representative of two or three independent experiments.
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tibody production by ELISA. Serum total IgE was
measured by a sandwich ELISA as described previ-
ously.28,29 Papain-specific IgG antibodies were de-
tected as described previously16 with modifications as
follows. Plates were coated with 10 μgml of papain
and blocked with ImmunoBlock (DS Pharma Bio-
medical, Osaka, Japan). Sera, biotinylated anti-mouse
IgE, and horseradish peroxidase (HRP)-conjugated
streptavidine were diluted with PBS containing 0.05%
Tween 20 and 120 volume of ImmunoBlock (150,
1250, and 12500 dilutions, respectively).16 To de-
tect papain-specific IgE, incubations with sera, bioti-
nylated anti-mouse IgE, and HRP-conjugated strepta-
vidine were conducted overnight at 4°C, for 60 min at
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Fig.　2　Papain patched on the backs of hairless mice induced papain-specifi c IgG anti-
bodies. Sera were collected from hairless mice shown in Figures 1 on day 8. Papain-spe-
cifi c IgG1 (A), IgG2a (B), and IgG2b (C) were measured by ELISA (serum dilutions: 
1/10000, 1/200, and 1/200, respectively). The average of the values for the Control group 
was set to zero in each of the panels. *p < 0.05 signifi cantly different from Control and #p 
< 0.05 signifi cantly different from PBS by a one-way ANOVA and Tukey post hoc test, 
and $p < 0.05 signifi cantly different from PBS by a t-test (two-tailed). Data shown are the 
means ± SDs for four or three mice/group and are representative of two or three indepen-
dent experiments.
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room temperature, and for 30 min at room tempera-
ture, respectively. The HRP-conjugated anti-IgG2a
monoclonal antibody (clone R19-15; BD Biosciences)
cross-reactive to IgG2c was used for detection of
IgG2c. To detect papain-specific IgG1, IgG2c, and
IgG2b, incubations with sera (15000, 1200, and 1
200 dilutions, respectively) and HRP-conjugated anti-
mouse IgG subclasses were conducted for 80 min at
37°C, respectively. The OD at 450 nm, from which
that at 570 nm was subtracted, was used as the signal
for papain specific antibodies.
STATISTICAL ANALYSIS
A one-way analysis of variance (ANOVA) with
Tukey’s multiple comparison test and unpaired t-test
(two-tailed) were used. Values of P < 0.05 were re-
garded as significant.
RESULTS
EPICUTANEOUS EXPOSURE OF THE BACKS
OF HAIRLESS MICE TO PAPAIN INDUCED SKIN
BARRIER DYSFUNCTION
Papain was applied in a patch to the backs of hairless
mice on days 0-6 and days 9-15. TEWL was measured
on days 9 and 16. The hairless phenotype of this
strain simplified the experimental protocol. V8 pro-
tease,27 a Staphylococcus aureus extracellular serine
protease showing a specificity of glutamate-specific
cleavage similar to S. aureus exfoliative toxins, was
used as a positive control in the measurement of
TEWL. In our previous report, TEWL was increased
in V8 protease-patched mice on day 7 after the appli-
cation on days 0-6.27 On day 9 after the two-day inter-
val from the application on days 0-6 (Fig. 1A, middle
panel), TEWL was higher in V8 protease-patched
mice than PBS-patched mice but was not in papain-
patched mice. TEWL was also higher in papain-
patched and V8 protease-patched mice than in mice
directly administered PBS onto their backs without
the patch with occlusion (Fig. 1A, Control). TEWL
was higher in papain-patched mice and V8 protease-
patched mice than in PBS-patched mice on day 16
(Fig. 1A, lower panel), the day after the application on
days 9-15. Thus, epicutaneous exposure to papain on
the backs of hairless mice induced skin barrier dys-
function, although the amount of papain (50 μg100
μl2 cm2site) used to reduce barrier function was
more than that of V8 protease (5 μg100 μl2 cm2
site).
EPICUTANEOUS EXPOSURE OF THE BACKS
OF HAIRLESS MICE TO PAPAIN UPREGULATED
SERUM TOTAL IgE LEVELS AND INDUCED
PAPAIN-SPECIFIC IgG PRODUCTION
Serum total IgE levels were higher in papain-patched
hairless mice than in PBS-patched mice on day 8, and
were also higher in V8 protease-patched mice on day
8 (Fig. 1B). On day 8 (Fig. 2), papain-specific IgG1
and IgG2b, but not IgG2a (Fig. 2A, C, B, respec-
tively), were induced in papain-patched hairless mice.
Epicutaneous Sensitization to Protease
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Fig.　3　Papain painted on the ear lobes of C57BL/6 mice induced papain-
specifi c IgE in a manner dependent on the protease activity of papain. Pa-
pain or that treated with E-64 was painted on the ear lobes of C57BL/6 
mice on days 0, 3, 7, 10, 21, 24, and 28. Sera were collected on days 17 
and 35. Total IgE (A) and papain-specifi c IgE (serum dilution: 1/50) (B) 
were measured by ELISA. The average of the values for the Vehicle group 
was set to zero in each of the panels in B. *p < 0.05 by a one-way ANOVA 
and Tukey post hoc test. Data shown are the means ± SDs for four or three 
mice/group and are representative of three independent experiments.
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On day 16, higher titers of all three subclasses of
papain-specific IgG examined were observed (data
not shown). Thus, the epicutaneous exposure of the
backs of hairless mice to papain upregulated serum
total IgE levels (Fig. 1B) and induced papain-specific
IgG production (Fig. 2). V8 protease also upregulated
serum total IgE levels (Fig. 1B).
EPICUTANEOUS EXPOSURE OF THE EAR
LOBES OF C57BL6 MICE TO PAPAIN INDUCED
PAPAIN-SPECIFIC IgE AND IgG PRODUCTION
IN A MANNER DEPENDENT ON THE CYSTEINE
PROTEASE ACTIVITY OF PAPAIN
Recently we reported that intranasal administration of
papain and recombinant Der f 1 without using adju-
vants such as Alum induced allergic airway inflamma-
tion and IgEIgG1 production in a manner dependent
of the protease activity of the protease allergens in an
inbred murine strain, C57BL6.16 We examined the
epicutaneous administration of papain in the same
strain. We painted the papain solution onto the ear
lobes of C57BL6 without tape stripping and without
the patch and occlusion on days 0, 3, 7, 10, 21, 24, and
28. Although no significant difference was observed
in serum total IgE on days 17 and 35 between the
papain-treated and the control vehicle-treated mice of
this strain (Fig. 3A), the production of IgE and IgG
subclasses specific to papain was observed (Fig. 3B,
Fig. 4, Papain). In contrast, papain treated with E64,
an irreversible inhibitor specific to cysteine pro-
teases, did not induce significant IgE and IgG produc-
tion specific to papain (Fig. 3B, 4, E64-papain). Thus,
epicutaneous exposure of the ear lobes of C57BL6
mice to papain induced the production of papain-
specific IgE and IgG antibodies and this was depend-
ent on the protease activity of papain. As the C57BL
6 strain lacks the gene for IgG2a but instead express
IgG2c,34 the HRP-conjugated anti-IgG2a monoclonal
Iida H et al.
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Fig.　4　Papain painted on the ear lobes of C57BL/6 mice induced papain-specifi c IgG antibodies 
in a manner dependent on the protease activity of papain. Sera used were identical to those ana-
lyzed in Figure 3. Papain-specifi c IgG1 (A), IgG2c (B), and IgG2b (C) were measured by ELISA 
(serum dilutions: 1/5000, 1/200, and 1/200, respectively). As the C57BL/6 mice lack the gene for 
IgG2a but instead express IgG2c, the HRP-conjugated anti-IgG2a monoclonal antibody cross-re-
active to IgG2c was used for detection of IgG2c. The average of the values for the Vehicle group 
was set to zero in each of the panels. *p < 0.05 by a one-way ANOVA and Tukey post hoc test. 
Data shown are the means ± SDs for four or three mice/group and are representative of three in-
dependent experiments.
B CA
0.6
0.4
0.2
0.0
Day 17
0.8
0.6
0.4
0.2
0.0
0.06
0.04
0.02
0.00
0.08
0.06
0.04
0.02
0.00
0.06
0.04
0.02
0.00
0.08
0.06
0.04
0.02
0.00
Day 35
* *
* *
*
* *
* *
Day 35 Day 35
Day 17 Day 17
P
ap
ai
n-
sp
ec
ifi
c 
lg
G
2c
 (
O
D
 4
50
 n
m
)
P
ap
ai
n-
sp
ec
ifi
c 
lg
G
2b
 (
O
D
 4
50
 n
m
)
P
ap
ai
n-
sp
ec
ifi
c 
lg
G
1 
(O
D
 4
50
 n
m
)
V
eh
ic
le
P
ap
ai
n
E
64
-p
ap
ai
n
V
eh
ic
le
P
ap
ai
n
E
64
-p
ap
ai
n
V
eh
ic
le
P
ap
ai
n
E
64
-p
ap
ai
n
antibody cross-reactive to IgG2c was used for detec-
tion of IgG2c (Fig. 4B).
DISCUSSION
The mite-derived indoor allergens, Der f 1 and Der p
1, and plant-derived occupational allergen, papain, be-
long to the same family of cysteine proteases, family
C1 of clan CA.3,35,36 In the present study, we used pa-
pain as a model protease allergen that mimics the
cysteine proteases contained in natural allergen
sources such as mites and pollen.1,37,38 We demon-
strated that the epicutaneous administration of papain
did not only disrupt skin barrier function (Fig. 1A),
but also induced IgE and IgG responses (Fig. 1B, 2-
4). Additionally, epicutaneously administered Staphy-
lococcus aureus V8 protease also exhibited the capac-
ity to reduce skin barrier function (Fig. 1) and
upregulate serum total IgE levels (Fig. 2). Upregula-
tion of total IgE levels was not observed in C57BL6
mice and this could be due to differences of the
strains and methods of administration between the
two experimental models.
The protease activity of papain markedly contrib-
uted to serum antibody production of IgE and IgG
subclasses (Fig. 3B, 4). We used the cysteine pro-
tease inhibitor, E64, which irreversibly binds to the
catalytic site of papain without altering its tertiary
structure.14,39 The inactivation of protease activity by
heat denaturation has been reported to disrupt the
tertiary structure andor cause oligomerization,
which are likely to affect the immunochemical prop-
erties of allergens such as antibody binding40,41 and
the T-cell response.14 Our results using E64-treated
papain indicate that elevated serum antibody produc-
tion is dependent on the cysteine protease activity of
papain, but not to conformational changes or aggre-
gation, which may cause different immune responses.
Considering the serum dilution factors and ODs in
ELISA for the papain-specific IgG subclasses, the
epicutaneous administration of papain induced the
most significant production of IgG1, the class-switch
to which and IgE Th2 cytokines contribute to, among
the IgG subclasses measured (Fig. 2, Fig. 4).
To the best of our knowledge, this is the first study
Epicutaneous Sensitization to Protease
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to report epicutaneous sensitization dependent on
protease activity of the antigen, which suggests that
epicutaneous exposure to environmental proteases
promotes allergic sensitization. Allergen source-
derived or microbe-derived proteases, some of which
are allergens (protease allergens), have been shown
to cause barrier breakdown and induce innate im-
mune responses in various cell types.1,3-7 The mouse
models described here should be prototype models,
which will be useful for analyzing the natural history
of allergic diseases initiated with epicutaneous sensi-
tization to proteases. We are now conducting further
analyses using these models to explore the mecha-
nisms of the protease-dependent epicutaneous sensi-
tization and its roles in allergic diseases.
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